|
Cuenca-Zamora EJ, Martinez C, Morales ML, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Alcolea-Guardiola C, Vidal-Garrido N, Lozano ML, Gonzalez-Conejero R, Teruel-Montoya R, Ferrer-Marin F. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model. Biomed Pharmacother. 2024 Dec;181:117712. doi: 10.1016/j.biopha.2024.117712. Epub 2024 Nov 26. PubMed PMID: 39603040.
AÑO: 2024; IF: 6.9
|
39603040
|
Pastor-Galan I, Pereira A, Arellano-Rodrigo E, Martin I, Mosquera-Orgueira A, Gomez-Casares MT, Hernandez-Sanchez A, Ferrer-Marin F, Mora E, Velez P, Ayala R, Angona A, de Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, Gonzalez de Villambrosia S, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin MA, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Garrote M, Ferrer B, Perez-Encinas M, Hernandez-Rivas JM, Bellosillo B, Alvarez-Larran A, Hernandez-Boluda JC. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis. Leukemia. 2024 Nov;38(11):2483-2486. doi: 10.1038/s41375-024-02389-2. Epub 2024 Aug 30. No abstract available. PubMed PMID: 39215061.
AÑO: 2024; IF: 12.8
|
|
Liu ZJ, Thom C, Nitulescu II, Pelish HE, Rimsza LM, Teruel-Montoya R, Ferrer-Marin F, Shair MD, Sola-Visner M. CDK8/19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes. Br J Haematol. 2024 Dec;205(6):2481-2486. doi: 10.1111/bjh.19836. Epub 2024 Oct 16. PubMed PMID: 39413769; PubMed Central PMCID: PMC11637730.
AÑO: 2024; IF: 5.1
|
|
Kiladjian JJ, Marin FF, Al-Ali HK, Alvarez-Larran A, Beggiato E, Bieniaszewska M, Breccia M, Buxhofer-Ausch V, Cerna O, Crisan AM, Danaila CD, De Stefano V, Dohner K, Empson V, Gora-Tybor J, Griesshammer M, Grosicki S, Guglielmelli P, Garcia-Gutierrez V, Heidel FH, Illes A, Tomuleasa C, James C, Koschmieder S, Krauth MT, Krejcy K, Lazaroiu MC, Mayer J, Nagy ZG, Nicolini FE, Palandri F, Pappa V, Reiter AJ, Sacha T, Schlager S, Schmidt S, Terpos E, Unger M, Wolfler A, Cirici BX, Klade C. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options. Ann Hematol. 2024 Jul;103(7):2299-2310. doi: 10.1007/s00277-024-05665-4. Epub 2024 Mar 4. PubMed PMID: 38438627; PubMed Central PMCID: PMC11224110.
AÑO: 2024; IF: 3.0
|
|
Morales ML, Cano H, de la Morena-Barrio B, Vives-Corrons JL, Cuenca-Zamora EJ, Garrido-Rodriguez P, Bento C, Pereira J, Martinez Nieto J, Chen-Liang TH, Fuster JL, Caracena S, Lozano ML, Teruel-Montoya R, Corral J, Ferrer-Marin F. CALRins5-mediated clonal hematopoiesis causes severe hemolytic anemia in a female PGK1Ser320Asn carrier. Blood Cancer J. 2025 Feb 1;15(1):8. doi: 10.1038/s41408-025-01216-w. No abstract available. PubMed PMID: 39893164; PubMed Central PMCID: PMC11787284.
AÑO: 2025; IF: 12.9
|